CA2095729A1 - Peptides solubles du recepteur du mannose - Google Patents

Peptides solubles du recepteur du mannose

Info

Publication number
CA2095729A1
CA2095729A1 CA002095729A CA2095729A CA2095729A1 CA 2095729 A1 CA2095729 A1 CA 2095729A1 CA 002095729 A CA002095729 A CA 002095729A CA 2095729 A CA2095729 A CA 2095729A CA 2095729 A1 CA2095729 A1 CA 2095729A1
Authority
CA
Canada
Prior art keywords
peptide
mannose receptor
ser
nucleic acid
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002095729A
Other languages
English (en)
Inventor
Raymond A. B. Ezekowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Children's Hospital
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2095729A1 publication Critical patent/CA2095729A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Of Gases By Adsorption (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002095729A 1990-11-06 1991-11-06 Peptides solubles du recepteur du mannose Abandoned CA2095729A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US609,915 1975-09-03
US60991590A 1990-11-06 1990-11-06
PCT/US1991/008320 WO1992007579A1 (fr) 1990-11-06 1991-11-06 Peptides solubles recepteurs de mannose

Publications (1)

Publication Number Publication Date
CA2095729A1 true CA2095729A1 (fr) 1992-05-07

Family

ID=24442877

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002095729A Abandoned CA2095729A1 (fr) 1990-11-06 1991-11-06 Peptides solubles du recepteur du mannose

Country Status (5)

Country Link
EP (1) EP0568539A4 (fr)
JP (1) JPH06501620A (fr)
AU (1) AU9040591A (fr)
CA (1) CA2095729A1 (fr)
WO (1) WO1992007579A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11510384A (ja) 1995-07-27 1999-09-14 インペリアル カレッジ オブ サイエンス，テクノロジー アンド メディシン 感染の出現を予測する方法
DE69836428T2 (de) * 1997-08-21 2007-09-27 Takara Bio Inc., Otsu Karzinostatische wirkstoffe
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
JP5007409B2 (ja) 2000-05-08 2012-08-22 セルデックス リサーチ コーポレーション 樹状細胞に対するヒトモノクローナル抗体
WO2004074432A2 (fr) 2003-01-31 2004-09-02 Celldex Therapeutics, Inc. Conjugues vaccinaux a base d'anticorps et leurs applications
US9259459B2 (en) 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
US8236318B2 (en) 2007-11-07 2012-08-07 Celldex Therapeutics Inc. Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
CA2741724C (fr) * 2008-11-27 2016-10-04 Bavarian Nordic A/S Promoteurs pour expression virale recombinante
GB201717977D0 (en) * 2017-10-31 2017-12-13 Univ Court Of The Univ Of Aberdeen Treatment of anaemia
WO2022002982A1 (fr) 2020-06-30 2022-01-06 Henriques Normark Birgitta Peptides dérivés du récepteur de mannose pour neutraliser des toxines formant des pores pour des utilisations thérapeutiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI900808A0 (fi) * 1987-08-20 1990-02-19 Childrens Medical Center Humant mannos bindande protein.
CA1322972C (fr) * 1988-03-07 1993-10-12 Pall Corporation Systeme d'absorption sans chauffage pour la purification et le fonctionnement d'air

Also Published As

Publication number Publication date
EP0568539A1 (fr) 1993-11-10
AU9040591A (en) 1992-05-26
JPH06501620A (ja) 1994-02-24
WO1992007579A1 (fr) 1992-05-14
EP0568539A4 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
EP1289564B1 (fr) Fusions et conjugues de recepteurs de lymphocytes t et procedes d'utilisation correspondants
CN100558745C (zh) 同种排斥反应的特异性抑制
US5270199A (en) Human mannose-binding protein
FI116943B (fi) Menetelmä kasvainkuoliotekijän reseptoria sisältävien fuusioproteiinien valmistamiseksi ja niitä koodaava DNA ja vektori
US5820866A (en) Product and process for T cell regulation
EP0991759A1 (fr) Membre ntn-2 de la famille des ligands du facteur de necrose tumorale (tnf)
WO1998055620A1 (fr) Element ntn-2 de la famille des ligands du tnf
EA022932B1 (ru) Димерные слитые белки vstm3 и связанные с ними композиции и способы
JPH06502301A (ja) 安定タンパク質コアに結合されたタンパク質ポリリガンド
WO1989001519A1 (fr) Proteine humaine liant le mannose
CA2276090A1 (fr) N-smases recombinees et acides nucleiques les codant
WO1999007738A2 (fr) Nouveau recepteur orphelin
JPH10511266A (ja) ヒト・インターロイキン−１１受容体
US7456263B2 (en) P53 binding T cell receptor molecules
WO1992007579A1 (fr) Peptides solubles recepteurs de mannose
CA1341530C (fr) Inhibiteur de l'angiogenine
AU2207999A (en) Novel nucleic acid and polypeptide
WO1999021997A1 (fr) Adn et polypeptides recepteurs des proteines de semaphorine a codage viral
JPH03284700A (ja) 機能性ポリペプチド
ES2315011T3 (es) Polipeptidos de semaforina.
US6187909B1 (en) Viral encoded semaphorin protein receptor polypeptides
JP2001500019A (ja) 顆粒球走化性タンパク質２変異体
JPH05503219A (ja) ヒトドーパミン作用性受容体活性を有するポリペプチド、これらのポリペプチドをコードする核酸、これらのポリペプチドに対して活性の物質をスクリーニングするためのかかるポリペプチドの使用
US6562949B1 (en) Antibodies to viral encoded semaphorin protein receptor polypeptides
JP3621883B2 (ja) ウイルスがコードするセマフォリンタンパク質受容体ｄｎａおよびポリペプチド

Legal Events

Date Code Title Description
FZDE Dead